Medical/Pharmaceuticals

Nippon Express (China) Signs Memorandum on Pharmaceutical Logistics Business Collaboration with Shanghai Shengsheng Logistics

TOKYO, July 2, 2021 /PRNewswire/ --  - Move Aimed at Enhancing Pharmaceutical Logistics Efforts - Nippon Express (China) Co., Ltd. (hereinafter "NE China"), a local subsidiary of Nippon Express Co., Ltd., concluded a memorandum on business collaboration with Shanghai Shengsheng Logistics Co., Lt...

2021-07-02 14:00 3064

China's Leading Health Insurance Platform QingSong Health Group and the World's Largest Insurance Company AXA Reached a Strategic Cooperation

BEIJING, July 2, 2021 /PRNewswire/ -- On June 25th, China's leading health insurance technology platform QingSong Health Group and AXA Insurance Group reached a strategic cooperation. The two parties will work together in in-depth exploration of insurance education, insurance innovation, health s...

2021-07-02 13:48 4243

Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for potential value of MEUR 70

STOCKHOLM, Sweden, July 2, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced today that it has signed a licence agreement under which Lipidor grants RELIFE S.r.l., part of leading international pharmaceutical company, Menarini Group, exclusive rights to re...

2021-07-02 05:32 2478

First Naturally-designed and Personalised Bioprosthesis SingValve Set to Revolutionise Heart Valve Surgery

SINGAPORE, July 1, 2021 /PRNewswire/ -- A naturally-designed human-like personalised heart valve bioprosthesis developed by a team of clinician-scientists from theNational University Health System (NUHS) looks set to be a game changer in the next generation of "personalised medicine" and further...

2021-07-01 21:00 3379

Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology

SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- Korea National Institute of Health (KNIH), Korea's top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology.

2021-07-01 21:00 2568

Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany

SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- A Phase 1 study on new drug candidate IDG16177 of novel oral treatment for type 2 diabetes, which is being developed by Ildong Pharmaceutical, is initiated inGermany. On June 28th (local time), Ildong Pharmaceutical obtained approval for the Phas...

2021-07-01 21:00 2666

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

* First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors * China sites to join the dose expansion part of the study to accelerate TJ- CD4B/ABL111 development * Results of TJ-L14B/ABL503 preclinical studies accepted for publica...

2021-07-01 20:00 13696

Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's

MELBOURNE, Australia and SAN FRANCISCO, July 1, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the United States Patent and Trademark Office (USPTO).  The patent secures a ...

2021-07-01 19:50 14061

Bactiguard receives payment from Zimmer Biomet

STOCKHOLM, July 1, 2021 /PRNewswire/ -- Following successful European regulatory clearance and market launch of Bactiguard-coated Zimmer Biomet trauma implants (ZNN Bactiguard), the initialUSD 1 million milestone payment has been released. "I am excited about our partnership with Zimmer Biomet a...

2021-07-01 17:47 1797

InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine Characterization

BOULDER, Colo., July 1, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Polio D-antigen quantification kit for r...

2021-07-01 15:00 1836

Elliott Publishes Letter on GlaxoSmithKline

Elliott believes GSK has a substantial value creation opportunity – 45% upside in its share price – ahead of Consumer Health separation and greater beyond Despite its strengths, GSK has a poor record of operational execution and value creation, leading to scepticism about the Company's future, an...

2021-07-01 14:45 2206

Joint Commission International publishes fourth edition of International Accreditation Standards for Laboratories

Standards and policies in latest edition become effective 1 January 2022 OAK BROOK, Ill., July 1, 2021 /PRNewswire/ -- Joint Commission International (JCI) today publishedJoint Commission International Accreditation Standards for Laboratories, Fourth Edition. The manual provides requirements for ...

2021-07-01 08:00 1780

European Wellness partners with China's provincial government to advance Education in Biological Regenerative Medicine

EDENKOBEN, Germany, July 1, 2021 /PRNewswire/ – European Wellness Biomedical Group (European Wellness) through its educational arm, European Wellness Academy (EWA), has signed a Letter of Intent (LOI) withZhifu People's Government of Yantai City,Shandong Province, China to establish the first In...

2021-07-01 08:00 4933

Joint Commission International publishes fourth edition of International Accreditation Standards for Laboratories

Standards and policies in latest edition become effective 1 January 2022 OAK BROOK, Ill., July 1, 2021 /PRNewswire/ -- Joint Commission International (JCI) today publishedJoint Commission International Accreditation Standards for Laboratories, Fourth Edition. The manual provides requirements for ...

2021-07-01 08:00 2168

Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints

SINGAPORE, July 1, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the exclusiveAsia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. ...

2021-07-01 08:00 6045

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

SYDNEY, June 30, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to provide an update on recent progress with its two pipeline assets, paxalisib and EVT801. Key Points * GBM AGILE pivotal study of paxalisib is...

2021-06-30 22:00 30887

VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung's Premium Mobile X-ray System

SEOUL, South Korea, June 30, 2021 /PRNewswire/ -- South Korean artificial intelligence (AI) developer, VUNO Inc., announced today a partnership with Samsung Electronics Co., Ltd., global medical device company to incorporate its AI-powered chest X-ray diagnostic solution, VUNO Med®-Chest X-ray™, ...

2021-06-30 21:00 2166

Antheia Announces $73M Series B to Commercialize Synthetic Biology Platform for Essential Medicines

Led by Viking Global Investors, the Series B round will be used to bring Antheia's first pharmaceutical compounds to market, expand its pipeline and scale production in global markets MENLO PARK, Calif., June 30, 2021 /PRNewswire/ -- Antheia, a synthetic biology company enabling next-generation ...

2021-06-30 20:00 2727

I-Mab Honored with Top Rankings by Institutional Investor

SHANGHAI and GAITHERSBURG, Md., June 30, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it was ranked among the top companies by leading gl...

2021-06-30 20:00 13097

Mentice receives order of total SEK 5.9 million from Baylis Medical Company

STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement withBaylis Medical Company ("Baylis")to provide simulation solutions. Based on t...

2021-06-30 18:19 1769
1 ... 631632633634635636637 ... 649